SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Introgen Therapeutics -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (457)12/22/2005 8:24:22 PM
From: zeta1961Respond to of 802
 
she is still suffering from jet lag.<g>

More like re-immersion trauma-g-..

Bernard and Tuck..I have no idea what to make of today's PR..except perhaps that Nance felt they had to address the h/n application to Wall Street by EOY?..the YMB inteligentsia has a conspiracy theory or 2..

They have been so guarded re: P3 enrollment and for a long time told shareholders that Advexin could be approved before they disclosed P3 results that I wait with baited breath to hear for the analyses-g-...

Still holding..

Elisabeth



To: Jibacoa who wrote (457)12/30/2005 4:03:14 PM
From: zeta1961Read Replies (1) | Respond to of 802
 
I keep hearing over at YMB that INGN's 6 million short shares are 'hedged' therefore we wouldn't see a short squeeze if the opportunity presented itself..Bernard and Tuck, do ya'll know anything about this?

PS..Bon 2006!!..Thanks so much for keeping me company here..

Elisabeth


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News